Table 1 Baseline characteristics of the newly diagnosed HCC patients, 2002-2009 (n = 73,918)
Variables | Male | Female | Total |
|---|---|---|---|
(n = 52,860) | (n = 21,058) | (n = 73,918) | |
Age | |||
 <50 | 9,830(18.6%) | 1,613(7.7%) | 11,443(15.5%) |
 50–79 | 38,783(73.4%) | 16,486(78.3%) | 55,269(74.8%) |
 ≥80 | 4,247(8.0%) | 2,959(14.1%) | 7,206(9.7%) |
The incidence rate/year of HCC | |||
 2002 | 6,122(11.6%) | 2,359(11.2%) | 8,481(11.5%) |
 2003 | 6,110(11.6%) | 2,331(11.1%) | 8,441(11.4%) |
 2004 | 6,346(12.0%) | 2,465(11.7%) | 8,811(11.9%) |
 2005 | 6,570(12.4%) | 2,495(11.8%) | 9,065(12.3%) |
 2006 | 6,528(12.3%) | 2,569(12.2%) | 9,097(12.3%) |
 2007 | 6,922(13.1%) | 2,723(12.9%) | 9,645(13.0%) |
 2008 | 7,100(13.4%) | 3,013(14.3%) | 10,113(13.7%) |
 2009 | 7,162(13.5%) | 3,103(14.7%) | 10,265(13.9%) |
Co-morbidities | |||
 Chronic liver disease/cirrhosis (ICD9: 573 &571) | 46,866(63.4%) | 19,071(25.8%) | 65,937(89.2%) |
 Viral hepatitis (ICD9:070) | 37,928(51.3%) | 15,445(20.9%) | 53,373(72.2%) |
CHM prescribed (single or formula) | |||
 2 years before HCC diagnosis | 11,576(21.9%) | 5,797(27.5%) | 17,373(23.5%) |
 2 years after HCC diagnosis | 8,711(16.5%) | 4,382(20.8%) | 13,093(17.7%) |
Single Chinese herbs prescribed | |||
 2 years before HCC diagnosis | 9,771(18.5%) | 4,979(23.6%) | 14,750(20.0%) |
 2 years after HCC diagnosis | 7,521(14.2%) | 3,813(18.1%) | 11,334(15.3%) |
Chinese herbal formula prescribed | |||
 2 years before HCC diagnosis | 11,238(21.3%) | 5,649(26.8%) | 16,887(22.8%) |
 2 years after HCC diagnosis | 8,425(15.9%) | 4,251(20.2%) | 12,676(17.1%) |